Ambulatory Infusion Offerings Gain Ground for Emergency Applications in the Parenteral Feeding Devices Market: Fact.MR
08 Apr 2021
CollaborateAcquisition
Researchers in the parenteral feeding devices mare are leveraging developments into remote monitoring and therapy management technologies for long-term revenue streams.
Fact.MR, Rockville MD: An ongoing report on the parenteral feeding devices market published by market research firm Fact.MR has estimated a steady growth rate for the coming months through 2021. The covid-19 pandemic has increased the demand for parenteral nutrition options especially among patients with severe cases of the disease, where enteral nutrition is difficult. While the market will face challenges in supply chains owing to shortages of man power and raw materials, the market is likely to witness a sustained growth through 2021, as governments relax lockdown restrictions in the near future.
According to a report by the American College of Gastroenterology, parenteral nutrition options include long term options including tunneled Hickman catheters, peripherally inserted central catheters, and under skin port implants. Alternatively, short-term options include central venous catheters which are set at the hospital, and removed before discharge.
Home based applications for parenteral feeding devices can be designed for short- and long-term use. However, clinician expertise is often recommended to minimized risks of complications. Electrolyte disturbances are common issues that manufacturers can consider to expand device portfolios for potential use in home settings.
“Widespread prevalence of malnourished children, increasing numbers of premature births, high natality rates, and cancer awareness, is generating requirements for vital nutrient administration to boost energy, and hydration of patients, bolstering adoption rates by healthcare practitioners for treating geriatric patients with chronic ailments, which will drive the market through the coming decade,” comments a Fact.MR analyst.
Request a report sample to gain detailed insights at
Key Takeaways from Fact.MR’s Parenteral Feeding Devices Market
Lipid emulsion administration applications are witnessing a strong growth rate owing to applications in pain management procedures.
Genetic and neonatal ailments supports adoption of parenteral feeding devices in children and newborns.
United States holds majority market share rising awareness about chronic disease treatment options.
China will reflect a faster rate of growth owing to a vast geriatric population and nutrient requirements for non-communicable diseases.
Parenteral Feeding Devices Market – Prominent Drivers
Widespread prevalence of GI tract diseases in younger and geriatric demographics supports the use of parenteral feeding devices.
Higher efficacy in terms of nutrient delivery is a key advantage that bolsters adoption rates.
Improvements to compliance rates, and applications in aesthetic medical care procedures boost demand in the market.
Parenteral Feeding Devices Market – Key Restraints
Healthcare complications associated with the disuse of gastrointestinal tracts with long term parenteral nutrition hurts market prospects.
High costs and requirements for frequent patient monitoring is a challenge hindering market growth.
Discover more about the parenteral feeding devices market with figures data tables and table of contents. You can also find detailed market segmentation at
Competitive Landscape
Major players in the parenteral feeding devices market include but are not limited to Amanta Healthcare, Micrel Medical Devices S.A., Baxter, Fresenius Kabi, B. Braun Melsungen AG, and Grifols S.A.
Leading players in the parenteral feeding devices market are engaged in strategies involving portfolio expansion, in addition to strategic mergers, acquisitions, and collaborations aimed towards knowledge and technology sharing objectives.
Inspiration Healthcare Group Plc for instance has announced the extension of its distribution agreements for its infusion devices with Mircel S.A., for operations in Ireland the UK.
In February 2021, BrainCool AB announced the receipt of the FDA approval for its new Cooral System to prevent oral mucositis including parenteral nutrition features.
In March 2021, the Parenteral Drug Association entered an agreement with the FDA’s Compounding Quality Center of Excellence for pharmaceutical compounders aimed towards the use of Good Manufacturing Practices in production.
More Insights on the Parenteral feeding devices Market
In its latest report, Fact.MR offers unbiased analysis of the global parenteral feeding devices market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (stationary infusion pumps, and ambulatory infusion pumps), application (ulcerative colitis, bowel obstruction, pediatric GI disorders, and short bowel syndrome from surgery), and end user (hospitals, clinics, ambulatory surgical centers, homecare settings, and elderly care settings) across seven regions (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa).
Request For No-Obligation Table Of Content
Explore Fact.MR’s Coverage on the Healthcare Domain
3D Printed Ophthalmic Implants Market: A recent study by Fact.MR on the 3D printed ophthalmic implants market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.
Ready-to-Use Laboratory test Kits Market: Fact.MR’s extensive coverage on the ready-to-use laboratory test kits market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.
Carbapenem-based Antibiotics Market: The global carbapenem-based antibiotics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Follow Us: LinkedIn | Twitter
Market Intelligence Services: Marketngage.com
Source: Fact.MR
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.